Tirzepatide activates both GLP-1 and GIP receptors, offering dual agonism
Brain fog becomes your new normal
For semaglutide, the typical starting dose is 0.25 mg weekly, increasing to 0.5 mg after four weeks, then to 1 mg, 1.7 mg, and eventually the target dose of 2.4 mg
Chlorpromazine is linked to extrapyramidal symptoms and must be administered intramuscularly ( This prospective randomized trial aimed to compare the efficacy and safety of Mel and Dex for sleep induction before EEG in children
Retatrutides unique mechanismactivating glucagon, GLP-1 and GIP receptorsreduces appetite, increases energy expenditure and improves insulin sensitivity
Our team will monitor you closely for safety